Clinical Trials Browser

Phase 1/2 × NETWORK × venetoclax × Clear all

NCT03504644 2026-02-25

Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03732703 2025-02-14

MyDRUG

Phase 1/2 Completed

103 enrolled

Plasma cell

Multiple Myeloma